107 related articles for article (PubMed ID: 9625433)
21. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
Higashihara J; Saito T; Berens ME; Welander CE
Cancer Chemother Pharmacol; 1988; 22(3):215-22. PubMed ID: 3136942
[TBL] [Abstract][Full Text] [Related]
22. Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.
Zhang X; Chen ZG; Khuri FR; Shin DM
Head Neck; 2007 Apr; 29(4):351-61. PubMed ID: 17163463
[TBL] [Abstract][Full Text] [Related]
23. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro.
Mahon FX; Chahine H; Barbot C; Pigeonnier V; Jazwiec B; Reiffers J; Ripoche J
Leukemia; 1997 May; 11(5):667-73. PubMed ID: 9180290
[TBL] [Abstract][Full Text] [Related]
24. Effect of all-trans retinoic acid on the growth of two nasopharyngeal cancer cell lines and its treatment potential in combination with cisplatin.
Hung SH; Lee FP; Su CH; Tseng H
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):695-704. PubMed ID: 22673737
[TBL] [Abstract][Full Text] [Related]
25. Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
Tosi P; Visani G; Ottaviani E; Gamberi B; Cenacchi A; Tura S
Eur J Haematol; 1993 Oct; 51(4):209-13. PubMed ID: 8243609
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
Mazumder ME; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Nov; 32(11):4851-60. PubMed ID: 23155251
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinoma.
Klatte T; Ittenson A; Röhl FW; Ecke M; Allhoff EP; Böhm M
Onkologie; 2008 Feb; 31(1-2):28-34. PubMed ID: 18268396
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
Engblom P; Rantanen V; Kulmala J; Grènman S
Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line.
Timmer-Bosscha H; de Vries EG; Meijer C; Oosterhuis JW; Mulder NH
Cancer Chemother Pharmacol; 1998; 41(6):469-76. PubMed ID: 9554591
[TBL] [Abstract][Full Text] [Related]
30. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
31. Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha.
Hoffmann W; Bläse MA; Santo-Hoeltje L; Herskind C; Bamberg M; Rodemann HP
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):991-8. PubMed ID: 10571207
[TBL] [Abstract][Full Text] [Related]
32. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
[TBL] [Abstract][Full Text] [Related]
33. Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.
Damle S; Beitler JJ; Haynes H; Camacho M; Wolf E; Wadler S
Am J Clin Oncol; 1999 Aug; 22(4):391-5. PubMed ID: 10440197
[TBL] [Abstract][Full Text] [Related]
34. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
May M; Helke C; Bock M; Hoschke B
Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.
Romanelli S; Perego P; Pratesi G; Carenini N; Tortoreto M; Zunino F
Cancer Chemother Pharmacol; 1998; 41(5):385-90. PubMed ID: 9523734
[TBL] [Abstract][Full Text] [Related]
36. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
37. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes.
Agarwal C; Hembree JR; Rorke EA; Eckert RL
Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114
[TBL] [Abstract][Full Text] [Related]
38. Effects of all-trans retinoic acid and interferon-gamma on expression of RAR beta gene in Tca8113 cells.
Chen WT; He RG; Liu XK; Zhou XJ
Chin J Dent Res; 1999 Dec; 2(3-4):25-30. PubMed ID: 10863413
[TBL] [Abstract][Full Text] [Related]
39. Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids.
Majewski S; Marczak M; Szmurlo A; Jablonska S; Bollag W
Cancer Lett; 1995 Feb; 89(1):117-24. PubMed ID: 7533656
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
